DCOY Decoy Therapeutics Inc.
Price Chart
Executive Summary
Decoy Therapeutics Inc. filed a DEFA14A (definitive additional proxy soliciting materials) providing notice of its 2026 Annual Meeting to be held virtually on July 14, 2026. The board recommends voting FOR all three proposals: election of three director nominees (Patricia Gauthier, Jonathan Lieber, Frederick E. Pierce), non-binding advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor for FY 2026. This is a routine management proxy solicitation with no dissident or activist campaign disclosed.
Actionable Insight
Routine annual meeting proxy notice with no contested items or activist involvement. Monitor for any dissident filings (DFAN14A) ahead of the July 14 meeting date. The $4M market cap and bearish analyst consensus suggest limited institutional interest — vote outcome is unlikely to move the stock.
Key Facts
- Annual Meeting scheduled for July 14, 2026, held virtually
- Three director nominees: Patricia Gauthier, Jonathan Lieber, Frederick E. Pierce
- Board recommends FOR all three proposals: director election, say-on-pay, auditor ratification
- Ernst & Young LLP proposed as independent registered public accounting firm for FY ending Dec 31, 2026
- Record date and share counts not disclosed in this filing
- Market cap of $4M with 0% analyst bullish consensus (0 Strong Buy, 0 Buy, 3 Hold, 1 Sell, 2 Strong Sell)
Financial Impact
No financial figures disclosed in this filing
Risk Factors
- No dissident or activist campaign identified — low risk of contested vote
- Micro-cap with $4M market cap and negative analyst sentiment (0% bullish) may face low shareholder turnout
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-256546 |
| Document: 0001193125-26-256546-index-headers.html | 0001193125-26-256546 |
| Document: 0001193125-26-256546-index.html | 0001193125-26-256546 |
| Document: 0001193125-26-256546.txt | 0001193125-26-256546 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 4, 2026
1d ago
|
DEFA14A
| $8.19 awaiting T+20 | awaiting T+20 | — | $6.61 (−19.28%) |
|
Apr 30, 2026
5w ago
|
10-K/A
| $6.05 $7.91 | ▲ +30.74% | ▲ +25.78% | $6.61 (+9.27%) |
|
Apr 2, 2026
9w ago
|
8-K
| $5.80 $6.05 | ▲ +4.31% | ▼ −5.57% | $6.61 (+13.98%) |
|
Mar 5, 2026
13w ago
|
8-K
| $7.00 $5.80 | ▼ −17.10% | ▼ −13.31% | $6.61 (−5.51%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access